Results 101 to 110 of about 5,971,609 (331)
Disclosure of conflicts of interest and credibility for the medical profession
Alain Braillon,1,* Bernard Granger2,* 1Alcohol Treatment Unit, Amiens University Hospital, Amiens, 2Department of Psychiatry, Tarnier Hospital (AP-HP), Paris, France, *Both authors contributed equally to this workWe were surprised by an unbalanced ...
Braillon A, Granger B
doaj
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan +9 more
wiley +1 more source
Conflict of Interest: Full Transparency
Gregory J. Golladay, MD +1 more
doaj +1 more source
Missing Conflict of Interest Disclosure [PDF]
Deirdre Stolmeier +2 more
openalex +1 more source
Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts +8 more
wiley +1 more source
Prevalence of financial conflicts of interest among panel members producing clinical practice guidelines in Canada and United States: cross sectional study [PDF]
openalex +1 more source
Labor Relations Conflict in the Workplace: Scale Development, Consequences and Solutions [PDF]
Because the goals of employers and employees are often incompatible, conflicts are inevitable and an essential part of organizational life. The three studies reported in this paper addressed the issues of identifying the dimensions of workplace conflicts
Xi, Meng +3 more
core +1 more source
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira +14 more
wiley +1 more source
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian +10 more
wiley +1 more source

